IMCR:NASDAQImmunocore Holdings plc analysis
Data as of Oct 4, 2026 - not real-time
- Latest price
- $29.71
- Risk: medium
- 6/10Medium risk
Summary
Immunocore Holdings plc trades at $29.71, with its moving averages tangled rather than clearly stacked — a neutral trend structure. The last 30 days have lost 18.1%. With RSI at 28.3 the momentum picture is oversold, alongside a bearish MACD signal. Price has been bracketed by support at $29.23 and resistance at $37.43.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 111.1% above today's level. Revenue is growing at 18.3% on a -4.2% profit margin.
On a 1-10 scale the risk profile lands at 6 — elevated. With 30-day volatility of 26.2%, a beta of 0.64 and a maximum drawdown of 30.9%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 3 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 111.1% above today's level. Revenue is growing at 18.3% on a -4.2% profit margin.
On a 1-10 scale the risk profile lands at 6 — elevated. With 30-day volatility of 26.2%, a beta of 0.64 and a maximum drawdown of 30.9%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 3 out of 10.
Top market events
- Immunocore's Q2 revenue beat reflects strong Kimmtrak demand, but an EPS miss and distributor stocking headwind cloud...
- Read Immunocore Holdings plc IMCR Q2 FY2026 earnings call transcript on Yahoo Finance to keep your investing strategy...
- Strong demand for Kimmtrak is fueling Immunocore's growth, while potential label expansion and late-2026 data could add...
Market outlook
Short term
< 1 yearNeutral
Model confidence3/103 out of 10
Key factors
- RSI at 28.3 signals oversold conditions
- Trading below the 200-day average of 32.18
- MACD momentum is negative
Medium term
1–3 yearsNeutral
Model confidence3/103 out of 10
Key factors
- RSI at 28.3 signals oversold conditions
- Trading below the 200-day average of 32.18
- Analyst targets imply +111.1% versus the current price
Long term
> 3 yearsNeutral
Model confidence3/103 out of 10
Key factors
- Negative profit margin of -4.2%
- Analyst targets imply +111.1% versus the current price
- Negative return on equity of -4.5%
Key metrics
Financial health
Revenue Growth18.30%
Profit Margin-4.20%
P/E Ratio-39.4
ROE-4.47%
ROA-0.16%
Debt/Equity103.61
P/B Ratio3.6
Op. Cash Flow$-34958000
Free Cash Flow$35.6M
Industry P/E29.7
Technical analysis
TrendNeutral
RSI28.3
Support$29.23
Resistance$37.43
MA 20$32.12
MA 50$33.97
MA 200$32.18
MACDBearish
VolumeIncreasing
Fear & Greed Index94.09
Valuation
Fair Value$25.96
Target Price$62.73
Upside/Downside111.13%
GradeFair
TypeGrowth
Risk assessment
Beta0.64
Volatility26.16%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.